Cargando…
Astrocytoma development following complete multiple myeloma remission in a 49-year-old patient: A case report
Multiple myeloma (MM), one of the B-cell non-Hodgkin lymphomas, is a bone marrow-derived, antibody-producing cancer of the plasma cells. In the advanced stages, the cancer cells frequently cause widespread osteolytic bone damage; however, in rare cases, MM also manifests as an intracranial plasmacyt...
Autores principales: | HAN, XIAOYAN, JIN, DIAN, ZHENG, GAOFENG, LUO, YI, CAI, ZHEN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786880/ https://www.ncbi.nlm.nih.gov/pubmed/24137217 http://dx.doi.org/10.3892/etm.2013.1179 |
Ejemplares similares
-
Baseline peripheral neuropathy was associated with age and a prognostic factor in newly diagnosed multiple myeloma patients
por: Dong, Mengmeng, et al.
Publicado: (2022) -
Disappearance of Acquired Hemophilia A after Complete Remission in a Multiple Myeloma Patient
por: Innao, Vanessa, et al.
Publicado: (2017) -
VAD chemotherapy as remission induction for multiple myeloma.
por: Anderson, H., et al.
Publicado: (1995) -
Bortezomib-Based Regimens for Newly Diagnosed Multiple Myeloma in China: A Report of 12-Year Real-World Data
por: He, Jingsong, et al.
Publicado: (2020) -
High serum IL-17A is associated with bone destruction in newly diagnosed multiple myeloma patients
por: Dong, Mengmeng, et al.
Publicado: (2022)